Skip to main content

Nextel Medical Corp.

جودة البيانات: 100%
MAJI
OTC Utilities Communications
KWD 0.04
▲ KWD 0.00 (9.38%)
القيمة السوقية: 1.43 M
السعر
KWD 0.04
القيمة السوقية
1.43 M
نطاق اليوم
نطاق 52 أسبوعًا
حجم التداول
فتح —
متوسط 50 يوم / 200 يوم
متوسط 50 يوم / 200 يوم

Quick Summary

النقاط الرئيسية

Negative free cash flow of -114,752.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-537.31

التقييم

PE (TTM)
-2.77
أقل من متوسط القطاع (3.69)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Utilities (448 نظير)
المقياس السهم وسيط القطاع
P/E -2.8 3.7
P/B 1.6
ROE % 7.9
Net Margin % 6.8
Rev Growth 5Y % 4.2
D/E 1.0

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -518,295.0
ROE N/A ROA -103659.00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -114,752.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.00
Interest Coverage -537.31 Asset Turnover 0.00
Working Capital -463,253 Tangible Book Value -463,253
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.77 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.00%
Market Cap 1.43 M Enterprise Value 1.43 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 22.14%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2020 FY2019 FY2012
Revenue 0.0 0.0 0.0
Net Income -435,950.0 -125,164.0 -6.18 M
EPS (Diluted)
Gross Profit
Operating Income -467,862.0 -125,164.0 -6.09 M
EBITDA
R&D Expenses
SG&A Expenses
D&A
Interest Expense 469.0 89,414.0
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2020 FY2019 FY2012
Total Assets 58,265.0 0.0 5,865.0
Total Liabilities 444,776.0 214,286.0 280,311.0
Shareholders' Equity -386,511.0 -214,286.0 -274,446.0
Total Debt
Cash & Equivalents 0.0 0.0 5,865.0
Current Assets 58,265.0 0.0 5,865.0
Current Liabilities 444,776.0 214,286.0 280,311.0